Rights and permissions
About this article
Cite this article
BTI-322 has potential in renal graft rejection. Inpharma Wkly. 1053, 11 (1996). https://doi.org/10.2165/00128413-199610530-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199610530-00020